Outcomes after donor stem cell transplant
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This study looks at how well patients do after receiving a stem cell transplant from a donor (called an allogeneic transplant). It aims to better understand the long-term outcomes and help improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have already received a stem cell transplant from a donor (not from yourself).
- You must be able to understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a genetic risk factor in a stem cell donor (called CHIP) may affect outcomes after an allogeneic (donor-to-recipient) stem cell transplant. It may help doctors better predict which donor factors are important for patient outcomes.
This study follows patients who have received a stem cell transplant from a donor to track and understand fungal infections that can occur afterward. By studying this carefully, researchers hope to better prevent and treat these serious infections in future patients.
This trial offers support and guidance for people who have had a donor stem cell transplant and are managing long-term side effects. It aims to help you better handle late effects and improve your quality of life after transplant.
This study looks at heart problems that can happen after a stem cell transplant from a donor (allogeneic). It aims to understand these risks better so doctors can help patients stay healthier after transplant.
This study tests whether a rehabilitation and activity program helps patients who are waiting for or undergoing an allogeneic stem cell transplant (a procedure where healthy blood-forming cells from a donor are given to replace damaged bone marrow). The goal is to see if staying active and doing rehabilitation exercises improves recovery and quality of life.
This study looks at the long-term health effects of hematopoietic (blood-forming) stem cell transplants. It may help doctors better understand and manage late side effects for children and teens after transplant.
Hear when a new Hematopoietic Stem Cell Transplant (HSCT) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.